NIH cancer and ivermectin results

From here

Ivermectin, a potential anticancer drug derived from an …

www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/

Ivermectin has powerful antitumor effects, including the inhibition of proliferation, metastasis, and angiogenic activity, in a variety of cancer …

Ivermectin has New Application in Inhibiting Colorectal …

pubmed.ncbi.nlm.nih.gov/34483925/

Colorectal cancer (CRC) is the third most common cancer worldwide and still lacks effective therapy. Ivermectin, an antiparasitic drug, has been shown …

Ivermectin has New Application in Inhibiting Colorectal …

www.ncbi.nlm.nih.gov/pmc/articles/PMC8415024/

Colorectal cancer (CRC) is the third most common cancer worldwide and still lacks effective therapy. Ivermectin, an antiparasitic drug, has been shown …

The multitargeted drug ivermectin: from an antiparasitic …

www.ncbi.nlm.nih.gov/pmc/articles/PMC5835698/

Ivermectin modifies the epigenetic signature and the self-renewal activity in the malignant cell due to its ability to mimic the SIN3-interaction that …

Ivermectin as an inhibitor of cancer stem‑like cells

pubmed.ncbi.nlm.nih.gov/29257278/

The aim of the present study was to demonstrate that ivermectin preferentially inhibited cancer stem‑like cells (CSC) in breast cancer cells and …

Anti-parasite drug ivermectin can suppress ovarian cancer …

www.ncbi.nlm.nih.gov/pmc/articles/PMC7272521/

Ivermectin, as an old anti-parasite drug, can suppress almost completely the growth of various human cancers, including ovarian cancer (OC). However …

Anti-parasite drug ivermectin can suppress ovarian cancer …

pubmed.ncbi.nlm.nih.gov/32549918/

Relevance: Ivermectin, as an old anti-parasite drug, can suppress almost completely the growth of various human cancers, including ovarian cancer …

Antitumor effects of ivermectin at clinically feasible …

pubmed.ncbi.nlm.nih.gov/32474842/

Purpose: Ivermectin is an antiparasitic drug that exhibits antitumor effects in preclinical studies, and as such is currently being repositioned for c …

Antibiotic ivermectin preferentially targets renal cancer …

pubmed.ncbi.nlm.nih.gov/28847725/

Renal cell carcinoma (RCC) is the most aggressive type of genitourinary cancer and highly resistant to current available therapies. In this work, we …

National Cancer Institute

www.cancer.gov/publications/dictionaries/cancer-drug/def/ivermectin

Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry …

Ivermectin: a systematic review from antiviral effects to …

pubmed.ncbi.nlm.nih.gov/32533071/

Ivermectin proposes many potentials effects to treat a range of diseases, with its antimicrobial, antiviral, and anti-cancer properties as a wonder …

Ivermectin induces apoptosis of esophageal squamous cell …

www.ncbi.nlm.nih.gov/pmc/articles/PMC8650430/

Taken together, these data suggest that ivermectin inhibits the growth of esophageal cancer both in vitro and in vivo. It had been reported that iverm …

Ivermectin inactivates the kinase PAK1 and blocks the PAK1 …

pubmed.ncbi.nlm.nih.gov/22495656/

Ivermectin is an old anti-parasitic antibiotic which selectively kills nematodes at a very low dose (0.2 mg/kg) by inhibiting their GABA …

Doxycycline, salinomycin, monensin and ivermectin …

pubmed.ncbi.nlm.nih.gov/31054863/

Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs Bioorg Med Chem Lett. 2019 Jul 1;29(13):1549-1554. doi …

The river blindness drug Ivermectin and related …

www.ncbi.nlm.nih.gov/pmc/articles/PMC4287931/

Ivermectin inhibits lung cancer xenograft growthin vivo. Beyond colon cancer, WNT-TCF signaling has been implicated in a number of other tumor types …

National Cancer Institute

www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/ivermectin

Frederick National Laboratory for Cancer Research . Bioinformatics, Big Data, and Cancer. Key Initiatives. Progress. Annual Report to the Nation …

Progress in Understanding the Molecular Mechanisms …

www.ncbi.nlm.nih.gov/pmc/articles/PMC6982461/

Ivermectin causes cell death in cancer cell lines by inducing PAK1-mediated cytostatic autophagy, caspase-dependent apoptosis and immunogenic cell …

Quercetin and cancer: new insights into its therapeutic …

www.ncbi.nlm.nih.gov/pmc/articles/PMC7063794/

Ovarian cancer is known as a serious malignancy that affects women’s reproductive tract and can considerably threat their health. A wide range of …

Ivermectin converts cold tumors hot and synergizes with …

pubmed.ncbi.nlm.nih.gov/33654071/

We show that treatment with the FDA-approved anti-parasitic drug ivermectin induces immunogenic cancer cell death (ICD) and robust T cell infiltration …

Ivermectin inhibits canine mammary tumor growth by …

www.ncbi.nlm.nih.gov/pmc/articles/PMC6679554/

Ivermectin inhibited the proliferation of cancer cells (Fig. 1 a and b) with less effects on a normal canine epithelial cell line (Fig. 1 d), which …